Product NDC: | 51079-440 |
Proprietary Name: | Levothyroxine Sodium |
Non Proprietary Name: | levothyroxine sodium |
Active Ingredient(s): | 50 ug/1 & nbsp; levothyroxine sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51079-440 |
Labeler Name: | UDL Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076187 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101029 |
Package NDC: | 51079-440-20 |
Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-440-20) > 1 TABLET in 1 BLISTER PACK (51079-440-01) |
NDC Code | 51079-440-20 |
Proprietary Name | Levothyroxine Sodium |
Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-440-20) > 1 TABLET in 1 BLISTER PACK (51079-440-01) |
Product NDC | 51079-440 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | levothyroxine sodium |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20101029 |
Marketing Category Name | ANDA |
Labeler Name | UDL Laboratories, Inc. |
Substance Name | LEVOTHYROXINE SODIUM |
Strength Number | 50 |
Strength Unit | ug/1 |
Pharmaceutical Classes | l-Thyroxine [EPC],Thyroxine [Chemical/Ingredient] |